As World Cancer Research Day is approaching on the 24th September with the theme this year as ‘Integrating diversity, advancing research, and achieving equity’, we celebrate our significant commitment to cancer research through our biobanking infrastructure. The Victorian Cancer Biobank (VCB) is a critical research infrastructure for cancer research and clinical trials. Through strong partnerships with major healthcare providers in Melbourne and across Victoria, VCB enables Victorians affected by cancer to empower research. We continue to create significant impacts to the research community in advancing scientific discoveries and boosting the local
A groundbreaking at home finger-prick blood test to measure patient cancer remission and reoccurrence could revolutionise cancer monitoring. The Victorian Cancer Biobank (VCB), which collects tissue, blood and data for cancer research and clinical trials in Victoria, hopes that this new technology may one day allow us to manage cancer reoccurrence as easily as monitoring blood sugar levels for diabetic patients. "It is estimated that 78 million people globally are currently in cancer remission, and the Cancer Biomarker biosensor test could potentially revolutionise cancer monitoring which is currently only available through a
To all VCB clients, The Victorian Cancer Biobank has over the years been adapting our biospecimen products and services to facilitate rapid technological advancements in Cancer Research. The demands for biospecimens in Cancer have evolved from simple banked specimens with associated diagnosis data to a wide range of highly specific biobanking requirements, such as prospective customised procurement, complicated selection criteria, clinical trial support etc. To continue providing the best service possible to support the research and development community, we are transitioning to a new service model, which will be introduced gradually in
On 2nd March, 2023, the Victorian Cancer Biobank (VCB) was proud to collaborate with the Murdoch Children’s Research Institute to co-host a seminar “Biobanking Quality: Exploring ISO20387 Accreditation pathways using a global perspective”. The local networking event brought together 25+ quality and biobanking leaders from across four Victorian-based biobanking groups to explore and discuss emerging gold-standard quality practices in biobanking. VCB was represented by various representatives from our VCB Strategic Advisory Group, VCB Management Operations Group and Victorian Cancer Agency. Inspired by a visiting special guest speaker Clare Allocca, Senior Advisor
The Victorian Cancer Biobank welcomes the Draft Australian Cancer Plan and are providing our position statement towards the plan. We believe biobanking infrastructure like ours play a significant part in contributing to the Objective 4: establishing strong and dynamic foundations in cancer control through research innovative technology and data. Please read our full position statement below.
With 2022 coming to an end, it is with great pride that we are reporting another successful year in supporting cancer research in Victoria, Australia and globally. We would like to thank the continued support of the community and the ongoing efforts of researchers in the journey to improve cancer outcomes. Please find our annual report of key achievements and some successful case studies relating to our contributions. View our Annual Key Achievements in FY 2021-22 here.
On behalf of the VCB consortium, we would like to wish you a Merry Christmas and a Happy New Year. We are also reminding you to kindly note on our site closures during this festive season. We look forward to working with you in the New Year. Austin Health: Closed 26th Dec 2022 to 2nd Jan 2023 Eastern Health: Closed 26th, 27th Dec 2022 and 2nd Jan 2023 Melbourne Health: Closed 22nd Dec 2022 to 2nd Jan 2023 Monash Health: Closed 26th Dec 2022 to 2nd Jan 2023 Peter Mac: Closed 23rd Dec 2022 from
The Victorian Cancer Biobank continues to strive to deliver our high-quality services and play our part to facilitate cancer research despite the challenges caused by the COVID-19 pandemic throughout the 2020-2021 year. View our Annual Key Achievements in FY 2020-21 here. We look forward to another year of success and improving cancer outcomes.
Our team at the VCB would like to send our warm greetings for the upcoming Christmas and New Year season. The VCB will be closed during this holiday period. Kindly refer to the details of each tissue bank sites closure period below: Austin Health: Closed 23rd Dec 2021 to 3rd Jan 2022 Eastern Health: Closed 22nd Dec 2021 to 3rd Jan 2022 Melbourne Health: Closed 22nd Dec 2021 to 3rd Jan 2022 Monash Health: Temporary closure Peter Mac: Closed 24th Dec to 3rd Jan 2022 Central Operations: Closed 24th Dec 2021 to 7th Jan 2022
We are seeking an International Advisor and a General Representative to join our Strategic Advisory Group at the Victorian Cancer Biobank. These roles will provide advice to the VCB to guide its strategic direction and priorities to achieve the Mission and Vision of the VCB, and to enable the long-term viability and sustainability of the consortium. If this opportunity interests you, please check out the description below for more details. For expression of interest in either of these roles, or nomination form, please contact: Dr Wayne Ng - email@example.com Nomination deadline: COB 12th